Your browser doesn't support javascript.
loading
Pentraxin-2 is Associated with Renal Fibrosis in Patients Undergoing Renal Biopsy.
Basturk, Taner; Ojalvo, David; Mazi, Emrah Erkan; Hasbal, Nuri Baris; Ozagari, Ayse Aysim; Ahbap, Elbis; Sakaci, Tamer; Koc, Yener; Sevinc, Mustafa; Unsal, Abdulkadir.
Afiliação
  • Basturk T; University of Health Sciences, Sisli Hamidiye Etfal Teaching and Research Hospital, Istanbul, Turkey.
  • Ojalvo D; Vardcentralen Wisby Soder, General Medicine, Gotland, Sweden.
  • Mazi EE; Sisli Hamidiye Etfal Teaching and Research Hospital, Department of Nephrology, Istanbul, Turkey.
  • Hasbal NB; Vardcentralen Wisby Soder, General Medicine, Gotland, Sweden.
  • Ozagari AA; Hakkari State Hospital, Department of Nephrology, Hakkari, Turkey.
  • Ahbap E; Sisli Hamidiye Etfal Teaching and Research Hospital, Department of Pathology, Istanbul, Turkey.
  • Sakaci T; Vardcentralen Wisby Soder, General Medicine, Gotland, Sweden.
  • Koc Y; Vardcentralen Wisby Soder, General Medicine, Gotland, Sweden.
  • Sevinc M; Cumhuriyet University, Faculty of Medicine, Department of Internal Medicine, Division of Nephrology, Sivas, Turkey.
  • Unsal A; Vardcentralen Wisby Soder, General Medicine, Gotland, Sweden.
Clinics (Sao Paulo) ; 75: e1809, 2020.
Article em En | MEDLINE | ID: mdl-33146353
OBJECTIVES: Progressive renal disease is characterized by histological changes in the kidney and fibrosis is a common outcome. Renal biopsy is the only diagnostic tool to evaluate these histopathological changes. Pentraxin-2 (PTX-2) is an anti-inflammatory constitutive plasma protein associated with the innate immune system. Recently, as a biomarker, the circulating level of PTX-2 is shown to be decreased in chronic fibrotic diseases. In this study, we aimed to investigate the relationship between renal fibrosis severity and serum PTX-2 levels in patients undergoing renal biopsy. METHODS: This cross-sectional study included 45 patients and 16 healthy individuals (HIs). The severity of renal fibrosis was evaluated according to the Banff and Sethi scoring systems by the same pathologist. PTX-2 was measured by an enzyme-linked immunosorbent assay and compared with the demographical, clinical, biochemical, and histopathological data of the patients and HIs. RESULTS: PTX-2 levels were lower in the biopsy group than in the HI group (p=0.12). Patients with moderate renal fibrosis had significantly lower serum PTX-2 levels than those in patients with minimal and mild fibrosis (p=0.017 and p=0.010, respectively). PTX-2 concentrations were correlated with serum albumin (r=0.30, p=0.016), and were negatively correlated with serum creatinine levels (rho=-0.42, p=0.01) and body mass index (r=-0.32, p=0.011). CONCLUSIONS: The results indicated that PTX-2 levels are significantly lower in patients with renal fibrosis than HIs, and declining further in patients with severe fibrosis.
Assuntos
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Proteína C-Reativa Tipo de estudo: Observational_studies / Prevalence_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: Clinics (Sao Paulo) Assunto da revista: MEDICINA Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Turquia País de publicação: Estados Unidos
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Proteína C-Reativa Tipo de estudo: Observational_studies / Prevalence_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: Clinics (Sao Paulo) Assunto da revista: MEDICINA Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Turquia País de publicação: Estados Unidos